InvestorsHub Logo
Followers 43
Posts 4926
Boards Moderated 0
Alias Born 08/25/2000

Re: None

Sunday, 02/11/2018 8:05:46 PM

Sunday, February 11, 2018 8:05:46 PM

Post# of 32016
Just got to LOVE this is you're a shareholder !! And he starts this week ?

From the Dr. Kendall hiring PR -->>


"The research and clinical response to Afrezza as a mealtime insulin supports ongoing efforts to establish this product as the standard of care for those living with type 1 or type 2 diabetes," said Dr. Kendall. "Afrezza is the only inhaled fast-acting mealtime insulin on the market, and offers the right patients a flexible, safe, and effective treatment option. I'm thrilled to join MannKind, and look forward to being part of a company that has the potential to transform the lives of so many people that are living with diabetes."

All my posts are in my opinion only,do your own DD and don't spend more then you can afford to lose

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News